Skip to main content
Premium Trial:

Request an Annual Quote

Oxford Nanopore Technologies: Guy Harmelin

Guy Harmelin has been appointed as a non-executive director of Oxford Nanopore Technologies, effective September 17. Previously, he was on the leadership team at Harel Insurance Investments and Financial Services, the largest insurance group in Israel. Prior to that, he was the cofounder and CEO of RondinX, a computational microbiome analysis company that was acquired by BiomX in 2017. Harmelin holds an MD from the University of Florence in Italy. 

The Scan

NFTs for Genome Sharing

Nature News writes that non-fungible tokens could be a way for people to profit from sharing genomic data.

Wastewater Warning System

Time magazine writes that cities and college campuses are monitoring sewage for SARS-CoV-2, an approach officials hope lasts beyond COVID-19.

Networks to Boost Surveillance

Scientific American writes that new organizations and networks aim to improve the ability of developing countries to conduct SARS-CoV-2 genomic surveillance.

Genome Biology Papers on Gastric Cancer Epimutations, BUTTERFLY, GUNC Tool

In Genome Biology this week: recurrent epigenetic mutations in gastric cancer, correction tool for unique molecular identifier-based assays, and more.